10-Q · 2026-11-06
Anika Therapeutics announces its Q3 financial results, highlighting growth strategies in the competitive surgical and medical instruments market.
| Name | Anika Therapeutics, Inc. |
|---|---|
| CIK | 0000898437 |
| Tickers | ANIK |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Accelerated filer |
| SIC | 3841 Surgical & Medical Instruments & Apparatus |
| EIN | 043145961 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (781) 457-9000 |
| Website | — |
| Investor website | — |
| Owner org | 08 Industrial Applications and Services |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Anika Therapeutics announces its Q3 financial results, highlighting growth strategies in the competitive surgical and medical instruments market.
Anika Therapeutics announces a 10% revenue increase in Q3 2026, driven by strong performance in its Commercial Channel and a new partnership.
1098 filing rows loaded from submissions recent; extra archives: CIK0000898437-submissions-001.json (92 filings, 1996-02-22 to 2003-12-18).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-06 | 10-Q | FORM 10-Q | 0001171843-26-007230 | 001-14027 | 261531337 | 34 | 7080121 | 1 | 1 | |
| 2026-11-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-26-007211 | 001-14027 | 261529324 | 34 | 443509 | 1 | 1 |
| 2026-08-07 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-005793 | 001-14027 | 261255518 | 33 | 5294 | |||
| 2026-08-05 | 4 | 4 | 0001193125-26-335269 | 6083 | ||||||
| 2026-07-31 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-001342 | 005-45573 | 261225865 | 34 | 7653 | |||
| 2026-07-29 | S-8 | FORM S-8 | 0001171843-26-005017 | 333-297791 | 261217907 | 33 | 192194 | 1 | 1 | |
| 2026-07-29 | 10-Q | FORM 10-Q | 0001171843-26-005012 | 001-14027 | 261217487 | 34 | 7231530 | 1 | 1 | |
| 2026-07-29 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-26-004977 | 001-14027 | 261213959 | 34 | 408721 | 1 | 1 |
| 2026-07-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002052113-26-000740 | 005-45573 | 261182501 | 34 | 11027 | |||
| 2026-07-14 | 8-K | FORM 8-K | 1.01,2.03,9.01 | 0001171843-26-004635 | 001-14027 | 261174897 | 34 | 1616694 | 1 | 1 |
| 2026-06-23 | 4 | 4 | 0001193125-26-279545 | 5093 | ||||||
| 2026-06-23 | 4 | 4 | 0001193125-26-279542 | 4989 | ||||||
| 2026-06-23 | 4 | 4 | 0001193125-26-279541 | 5009 | ||||||
| 2026-06-23 | 4 | 4 | 0001193125-26-279539 | 5011 | ||||||
| 2026-06-23 | 4 | 4 | 0001193125-26-279535 | 5008 | ||||||
| 2026-06-23 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001171843-26-004253 | 001-14027 | 261111038 | 34 | 430876 | 1 | 1 |
| 2026-06-08 | DEFA14A | DEFA14A | 0001140361-26-024374 | 001-14027 | 261071210 | 34 | 208003 | |||
| 2026-06-05 | 4 | 4 | 0001193125-26-259520 | 8948 | ||||||
| 2026-06-01 | DEFA14A | DEFA14A | 0001140361-26-023475 | 001-14027 | 261048142 | 34 | 39661 | |||
| 2026-05-04 | 4 | 4 | 0001193125-26-202704 | 5182 | ||||||
| 2026-04-30 | 4 | 4 | 0001193125-26-197887 | 5230 | ||||||
| 2026-04-30 | 10-Q | FORM 10-Q | 0001171843-26-002852 | 001-14027 | 26919197 | 34 | 6002337 | 1 | 1 | |
| 2026-04-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-000113 | 005-45573 | 26916922 | 34 | 7526 | |||
| 2026-04-29 | 8-K | FORM 8-K | 2.02,5.02,9.01 | 0001171843-26-002799 | 001-14027 | 26910530 | 34 | 408789 | 1 | 1 |
| 2026-04-28 | ARS | ARS | 0001140361-26-017490 | 001-14027 | 26908848 | 34 | 8548366 | |||
| 2026-04-28 | DEFA14A | DEFA14A | 0001140361-26-017489 | 001-14027 | 26908822 | 34 | 3688554 | |||
| 2026-04-28 | DEF 14A | DEF 14A | 0001140361-26-017488 | 001-14027 | 26908769 | 34 | 11344742 | 1 | 1 | |
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-000682 | 005-45573 | 26797815 | 34 | 7297 | |||
| 2026-03-23 | 4 | 4 | 0001193125-26-120005 | 10844 | ||||||
| 2026-03-17 | 4 | 4 | 0001193125-26-111511 | 15634 | ||||||
| 2026-03-17 | 4 | 4 | 0001193125-26-111502 | 10420 | ||||||
| 2026-03-17 | 4 | 4 | 0001193125-26-111494 | 16540 | ||||||
| 2026-03-17 | 4 | 4 | 0001193125-26-111492 | 15609 | ||||||
| 2026-03-11 | 4 | 4 | 0001193125-26-102240 | 8935 | ||||||
| 2026-03-11 | 4 | 4 | 0001193125-26-102239 | 9563 | ||||||
| 2026-03-11 | 4 | 4 | 0001193125-26-102238 | 8913 | ||||||
| 2026-03-03 | 10-K | FORM 10-K | 0001171843-26-001275 | 001-14027 | 26710193 | 34 | 11128695 | 1 | 1 | |
| 2026-02-26 | 8-K | 8-K | 2.02,5.02,9.01 | 0001193125-26-073401 | 001-14027 | 26681696 | 34 | 406745 | 1 | 1 |
| 2026-02-03 | 4 | 4 | 0001193125-26-036129 | 8895 | ||||||
| 2026-01-27 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000902664-26-000511 | 005-45573 | 26567679 | 34 | 8674 | |||
| 2026-01-08 | 8-K | 8-K | 2.02,5.02,9.01 | 0001193125-26-007655 | 001-14027 | 26519565 | 34 | 557346 | 1 | 1 |
| 2026-01-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-002059 | 005-45573 | 26519286 | 34 | 21471 | |||
| 2025-11-21 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000902664-25-005133 | 005-45573 | 251504807 | 34 | 10600 | |||
| 2025-11-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-108057 | 005-45573 | 251460273 | 34 | 21206 | |||
| 2025-11-05 | S-8 | FORM S-8 | 0001171843-25-007033 | 333-291282 | 251453729 | 33 | 191923 | 1 | 1 | |
| 2025-11-05 | 10-Q | FORM 10-Q | 0001171843-25-007032 | 001-14027 | 251453709 | 34 | 7445881 | 1 | 1 | |
| 2025-11-05 | 8-K | FORM 8-K | 2.02,8.01,9.01 | 0001171843-25-007003 | 001-14027 | 251451767 | 34 | 392405 | 1 | 1 |
| 2025-10-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-003599 | 005-45573 | 251399669 | 34 | 10847 | |||
| 2025-07-30 | 10-Q | FORM 10-Q | 0001171843-25-004826 | 001-14027 | 251167174 | 34 | 7329338 | 1 | 1 | |
| 2025-07-30 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-25-004810 | 001-14027 | 251163956 | 34 | 402996 | 1 | 1 |
| 2025-07-30 | 8-K | FORM 8-K | 7.01,9.01 | 0001171843-25-004809 | 001-14027 | 251163945 | 34 | 226527 | 1 | 1 |
| 2025-07-24 | UPLOAD | filename1.pdf | 0000000000-25-007779 | 001-14027 | 39801 | |||||
| 2025-07-17 | CORRESP | filename1.htm | 0001193125-25-160537 | 48064 | ||||||
| 2025-06-24 | 4 | xslF345X05/ownership.xml | 0001171843-25-004072 | 5058 | ||||||
| 2025-06-24 | 4 | xslF345X05/ownership.xml | 0001171843-25-004071 | 5054 | ||||||
| 2025-06-24 | 4 | xslF345X05/ownership.xml | 0001171843-25-004070 | 5063 | ||||||
| 2025-06-24 | 4 | xslF345X05/ownership.xml | 0001171843-25-004069 | 6082 | ||||||
| 2025-06-24 | 4 | xslF345X05/ownership.xml | 0001171843-25-004067 | 5034 | ||||||
| 2025-06-24 | 4 | xslF345X05/ownership.xml | 0001171843-25-004065 | 5140 | ||||||
| 2025-06-24 | 4 | xslF345X05/ownership.xml | 0001171843-25-004064 | 5053 | ||||||
| 2025-06-24 | 4 | xslF345X05/ownership.xml | 0001171843-25-004063 | 5058 | ||||||
| 2025-06-24 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001171843-25-004062 | 001-14027 | 251069995 | 34 | 406553 | 1 | 1 |
| 2025-06-18 | UPLOAD | filename1.pdf | 0000000000-25-006390 | 001-14027 | 46324 | |||||
| 2025-06-05 | 4 | xslF345X05/ownership.xml | 0001171843-25-003729 | 9351 | ||||||
| 2025-05-09 | 10-Q | FORM 10-Q | 0001171843-25-003019 | 001-14027 | 25929716 | 34 | 7106946 | 1 | 1 | |
| 2025-05-09 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-25-003005 | 001-14027 | 25928377 | 34 | 343239 | 1 | 1 |
| 2025-04-28 | ARS | ARS | 0001140361-25-016084 | 001-14027 | 25881681 | 34 | 1087029 | |||
| 2025-04-28 | DEFA14A | DEFA14A | 0001140361-25-016083 | 001-14027 | 25881670 | 34 | 2797313 | |||
| 2025-04-28 | DEF 14A | DEF 14A | 0001140361-25-016082 | 001-14027 | 25881666 | 34 | 10828096 | 1 | 1 | |
| 2025-04-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001576419-25-000696 | 005-45573 | 25844633 | 34 | 10944 | |||
| 2025-04-11 | 3 | xslF345X02/ownership.xml | 0001171843-25-002159 | 12180 | ||||||
| 2025-04-10 | 8-K | FORM 8-K | 5.02 | 0001171843-25-002148 | 001-14027 | 25828378 | 34 | 196239 | 1 | 1 |
| 2025-03-18 | 4 | xslF345X05/ownership.xml | 0001171843-25-001534 | 14767 | ||||||
| 2025-03-18 | 4 | xslF345X05/ownership.xml | 0001171843-25-001533 | 8645 | ||||||
| 2025-03-18 | 4 | xslF345X05/ownership.xml | 0001171843-25-001532 | 14818 | ||||||
| 2025-03-18 | 4 | xslF345X05/ownership.xml | 0001171843-25-001531 | 15801 | ||||||
| 2025-03-17 | 10-K | FORM 10-K | 0001171843-25-001486 | 001-14027 | 25741716 | 34 | 10815261 | 1 | 1 | |
| 2025-03-13 | 4 | xslF345X05/ownership.xml | 0001171843-25-001470 | 9161 | ||||||
| 2025-03-13 | 4 | xslF345X05/ownership.xml | 0001171843-25-001468 | 9210 | ||||||
| 2025-03-13 | 4 | xslF345X05/ownership.xml | 0001171843-25-001467 | 10185 | ||||||
| 2025-03-12 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-25-001437 | 001-14027 | 25731818 | 34 | 400125 | 1 | 1 |
| 2025-03-11 | 4 | xslF345X05/ownership.xml | 0001171843-25-001406 | 9383 | ||||||
| 2025-03-11 | 4 | xslF345X05/ownership.xml | 0001171843-25-001405 | 9473 | ||||||
| 2025-03-11 | 4 | xslF345X05/ownership.xml | 0001171843-25-001404 | 10447 | ||||||
| 2025-03-11 | 8-K | FORM 8-K | 2.01,7.01,9.01 | 0001171843-25-001388 | 001-14027 | 25725894 | 34 | 224472 | 1 | 1 |
| 2025-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-001508 | 005-45573 | 25594558 | 34 | 11948 | |||
| 2025-01-23 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000354204-25-000493 | 005-45573 | 25549988 | 34 | 8802 | |||
| 2024-11-08 | SC 13G/A | us0352551081_110824.txt | 0002012383-24-003689 | 005-45573 | 241439846 | 34 | 13876 | |||
| 2024-11-04 | 10-Q | FORM 10-Q | 0001171843-24-005993 | 001-14027 | 241424271 | 34 | 6236239 | 1 | 1 | |
| 2024-10-31 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-24-005923 | 001-14027 | 241412424 | 34 | 418986 | 1 | 1 |
| 2024-10-31 | 8-K | FORM 8-K | 2.01,7.01,9.01 | 0001171843-24-005922 | 001-14027 | 241412418 | 34 | 229842 | 1 | 1 |
| 2024-10-23 | SC 13G/A | us0352551081_102324.txt | 0002012383-24-001796 | 005-45573 | 241389797 | 34 | 13864 | |||
| 2024-10-04 | 4 | xslF345X05/ownership.xml | 0001171843-24-005510 | 9355 | ||||||
| 2024-08-08 | 10-Q | FORM 10-Q | 0001171843-24-004615 | 001-14027 | 241189693 | 34 | 5728488 | 1 | 1 | |
| 2024-08-08 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-24-004607 | 001-14027 | 241188397 | 34 | 391302 | 1 | 1 |
| 2024-07-11 | 4 | xslF345X05/ownership.xml | 0001171843-24-003910 | 5063 | ||||||
| 2024-07-11 | 4 | xslF345X05/ownership.xml | 0001171843-24-003909 | 5059 | ||||||
| 2024-07-11 | 4 | xslF345X05/ownership.xml | 0001171843-24-003908 | 5068 | ||||||
| 2024-07-11 | 4 | xslF345X05/ownership.xml | 0001171843-24-003907 | 6086 | ||||||
| 2024-07-11 | 4 | xslF345X05/ownership.xml | 0001171843-24-003906 | 5039 | ||||||
| 2024-07-11 | 4 | xslF345X05/ownership.xml | 0001171843-24-003905 | 5145 | ||||||
| 2024-07-11 | 4 | xslF345X05/ownership.xml | 0001171843-24-003904 | 5058 | ||||||
| 2024-07-11 | 4 | xslF345X05/ownership.xml | 0001171843-24-003903 | 5062 | ||||||
| 2024-07-11 | 8-K | FORM 8-K | 5.07 | 0001171843-24-003900 | 001-14027 | 241112204 | 34 | 200964 | 1 | 1 |
| 2024-06-25 | DEFA14A | DEFA14A | 0001171843-24-003640 | 001-14027 | 241069277 | 34 | 59784 | |||
| 2024-06-11 | ARS | ARS | 0001193125-24-159222 | 001-14027 | 241036658 | 34 | 13591865 | |||
| 2024-06-11 | DEF 14A | DEF 14A | 0001193125-24-159219 | 001-14027 | 241036637 | 34 | 4371064 | 1 | 1 | |
| 2024-06-05 | 4 | xslF345X05/ownership.xml | 0001171843-24-003315 | 5142 | ||||||
| 2024-06-05 | 4 | xslF345X05/ownership.xml | 0001171843-24-003314 | 7971 | ||||||
| 2024-06-05 | 4 | xslF345X05/ownership.xml | 0001171843-24-003313 | 5060 | ||||||
| 2024-06-05 | 3 | xslF345X02/ownership.xml | 0001171843-24-003312 | 9877 | ||||||
| 2024-06-05 | 3 | xslF345X02/ownership.xml | 0001171843-24-003311 | 9943 | ||||||
| 2024-06-05 | 3 | xslF345X02/ownership.xml | 0001171843-24-003310 | 9979 | ||||||
| 2024-05-31 | S-8 | FORM S-8 | 0001171843-24-003188 | 333-279870 | 241009844 | 33 | 190299 | |||
| 2024-05-30 | SC 13D/A | ANIKA THERAPEUTICS, INC. | 0000902664-24-003936 | 005-45573 | 241005938 | 34 | 74365 | |||
| 2024-05-28 | 8-K | FORM 8-K | 1.01,5.02,7.01,9.01 | 0001171843-24-003136 | 001-14027 | 24992908 | 34 | 398182 | 1 | 1 |
| 2024-05-08 | 10-Q | FORM 10-Q | 0001171843-24-002682 | 001-14027 | 24927518 | 34 | 5122531 | 1 | 1 | |
| 2024-05-08 | 8-K | FORM 8-K | 5.02,9.01 | 0001171843-24-002673 | 001-14027 | 24926217 | 34 | 475905 | 1 | 1 |
| 2024-05-08 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-24-002672 | 001-14027 | 24926106 | 34 | 342830 | 1 | 1 |
| 2024-04-26 | 10-K/A | FORM 10-K/A | 0001171843-24-002274 | 001-14027 | 24879052 | 34 | 1676289 | 1 | 1 | |
| 2024-04-05 | SC 13G/A | us0352551081_040424.txt | 0001086364-24-007359 | 005-45573 | 24825626 | 34 | 13610 | |||
| 2024-03-19 | 4 | xslF345X05/ownership.xml | 0001171843-24-001461 | 8140 | ||||||
| 2024-03-19 | 4 | xslF345X05/ownership.xml | 0001171843-24-001460 | 8138 | ||||||
| 2024-03-19 | 4 | xslF345X05/ownership.xml | 0001171843-24-001459 | 8092 | ||||||
| 2024-03-19 | 4 | xslF345X05/ownership.xml | 0001171843-24-001458 | 8139 | ||||||
| 2024-03-15 | 10-K | FORM 10-K | 0001171843-24-001380 | 001-14027 | 24753417 | 34 | 9524232 | 1 | 1 | |
| 2024-03-13 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-24-001322 | 001-14027 | 24746008 | 34 | 401976 | 1 | 1 |
| 2024-03-12 | 4 | xslF345X05/ownership.xml | 0001171843-24-001307 | 22115 | ||||||
| 2024-03-12 | 4 | xslF345X05/ownership.xml | 0001171843-24-001306 | 21107 | ||||||
| 2024-03-12 | 4 | xslF345X05/ownership.xml | 0001171843-24-001305 | 15490 | ||||||
| 2024-03-12 | 4 | xslF345X05/ownership.xml | 0001171843-24-001304 | 21056 | ||||||
| 2024-03-06 | SC 13D/A | ANIKA THERAPEUTICS, INC. | 0000902664-24-002242 | 005-45573 | 24727727 | 34 | 120659 | |||
| 2024-02-26 | 8-K | FORM 8-K | 5.02,9.01 | 0001171843-24-000972 | 001-14027 | 24673775 | 34 | 188678 | 1 | 1 |
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020290 | 005-45573 | 24627418 | 34 | 13220 | |||
| 2024-02-09 | SC 13G/A | SC 13G/A | 0001104659-24-012716 | 005-45573 | 24613005 | 34 | 118914 | |||
| 2024-02-09 | SC 13G/A | SEC SCHEDULE 13G | 0000354204-24-003106 | 005-45573 | 24612349 | 34 | 19626 | |||
| 2024-01-24 | SC 13G/A | us0352551081_012424.txt | 0001086364-24-002362 | 005-45573 | 24555935 | 34 | 13614 | |||
| 2024-01-22 | SC 13G/A | Anika_Therapeutics_Inc.txt | 0000093751-24-000041 | 005-45573 | 24547435 | 34 | 8569 | |||
| 2024-01-22 | S-8 POS | S-8 POS | 0001171843-24-000329 | 333-276622 | 24547273 | 33 | 163432 | |||
| 2024-01-19 | S-8 | FORM S-8 | 0001171843-24-000313 | 333-276622 | 24546253 | 33 | 56085 | |||
| 2024-01-12 | 3/A | xslF345X02/ownership.xml | 0001171843-24-000241 | 4186 | ||||||
| 2023-11-03 | 10-Q | FORM 10-Q | 0001171843-23-006687 | 001-14027 | 231373805 | 34 | 5857114 | 1 | 1 | |
| 2023-11-02 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-23-006678 | 001-14027 | 231372407 | 34 | 380504 | 1 | 1 |
| 2023-10-06 | SC 13G/A | us0352551081_100523.txt | 0001306550-23-010077 | 005-45573 | 231313874 | 34 | 13642 | |||
| 2023-10-03 | 4 | xslF345X05/ownership.xml | 0001171843-23-006018 | 9078 | ||||||
| 2023-09-21 | 8-K | FORM 8-K | 7.01,9.01 | 0001171843-23-005813 | 001-14027 | 231267753 | 34 | 3929088 | 1 | 1 |
| 2023-09-11 | SC 13D/A | ANIKA THERAPEUTICS, INC. | 0000902664-23-004717 | 005-45573 | 231246567 | 34 | 59649 | |||
| 2023-08-17 | SC 13D | ANIKA THERAPEUTICS, INC. | 0000902664-23-004496 | 005-45573 | 231179838 | 34 | 82242 | |||
| 2023-08-11 | 4 | xslF345X05/ownership.xml | 0001171843-23-005271 | 9326 | ||||||
| 2023-08-08 | S-8 | FORM S-8 | 0001171843-23-005115 | 333-273812 | 231152575 | 33 | 82088 | |||
| 2023-08-08 | 10-Q | FORM 10-Q | 0001171843-23-005114 | 001-14027 | 231152528 | 34 | 5752171 | 1 | 1 | |
| 2023-08-08 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-23-005107 | 001-14027 | 231151406 | 34 | 383878 | 1 | 1 |
| 2023-06-26 | 3 | xslF345X02/ownership.xml | 0001171843-23-004119 | 12000 | ||||||
| 2023-06-21 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001171843-23-004058 | 001-14027 | 231030543 | 34 | 412986 | 1 | 1 |
| 2023-06-16 | 4 | xslF345X04/ownership.xml | 0001171843-23-003963 | 4959 | ||||||
| 2023-06-16 | 4 | xslF345X04/ownership.xml | 0001171843-23-003962 | 4927 | ||||||
| 2023-06-16 | 4 | xslF345X04/ownership.xml | 0001171843-23-003961 | 4955 | ||||||
| 2023-06-16 | 4 | xslF345X04/ownership.xml | 0001171843-23-003960 | 4964 | ||||||
| 2023-06-16 | 4 | xslF345X04/ownership.xml | 0001171843-23-003959 | 4935 | ||||||
| 2023-06-16 | 4 | xslF345X04/ownership.xml | 0001171843-23-003958 | 5041 | ||||||
| 2023-06-16 | 4 | xslF345X04/ownership.xml | 0001171843-23-003957 | 4954 | ||||||
| 2023-05-09 | 10-Q | FORM 10-Q | 0001171843-23-003106 | 001-14027 | 23903385 | 34 | 5037445 | 1 | 1 | |
| 2023-05-09 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-23-003096 | 001-14027 | 23902097 | 34 | 320341 | 1 | 1 |
| 2023-05-01 | ARS | ARS | 0001193125-23-130734 | 001-14027 | 23875292 | 34 | 8976276 | |||
| 2023-05-01 | DEFA14A | DEFA14A | 0001193125-23-130728 | 001-14027 | 23875211 | 34 | 901470 | |||
| 2023-05-01 | DEF 14A | DEF 14A | 0001193125-23-130714 | 001-14027 | 23875171 | 34 | 7696259 | 1 | 1 | |
| 2023-04-28 | 4 | xslF345X04/ownership.xml | 0001171843-23-002685 | 10105 | ||||||
| 2023-04-28 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-124376 | 001-14027 | 23860261 | 34 | 143532 | 1 | 1 |
| 2023-04-25 | PRER14A | PRER14A | 0001193125-23-115473 | 001-14027 | 23845631 | 34 | 8088116 | 1 | 1 | |
| 2023-04-17 | 4 | xslF345X04/ownership.xml | 0001171843-23-002340 | 5007 | ||||||
| 2023-04-17 | 3 | xslF345X02/ownership.xml | 0001171843-23-002339 | 10335 | ||||||
| 2023-04-13 | 8-K | 8-K | 1.01,5.02,7.01,9.01 | 0001193125-23-100714 | 001-14027 | 23819171 | 34 | 279442 | 1 | 1 |
| 2023-04-06 | PRRN14A | ANIKA THERAPEUTICS, INC. | 0000902664-23-002514 | 001-14027 | 23807204 | 34 | 349161 | |||
| 2023-04-05 | UPLOAD | filename1.pdf | 0000000000-23-003424 | 50023 | ||||||
| 2023-04-05 | CORRESP | filename1.htm | 0001193125-23-091830 | 21950 | ||||||
| 2023-04-05 | PRER14A | PRER14A | 0001193125-23-091827 | 001-14027 | 23801619 | 34 | 7508275 | 1 | 1 | |
| 2023-04-04 | UPLOAD | filename1.pdf | 0000000000-23-003384 | 44338 | ||||||
| 2023-03-30 | PREC14A | ANIKA THERAPEUTICS, INC. | 0000902664-23-002420 | 001-14027 | 23781705 | 34 | 1175983 | |||
| 2023-03-27 | DEFA14A | DEFA14A | 0001193125-23-079900 | 001-14027 | 23761591 | 34 | 22182 | |||
| 2023-03-27 | PREC14A | PREC14A | 0001193125-23-079887 | 001-14027 | 23761555 | 34 | 7542635 | 1 | 1 | |
| 2023-03-16 | 10-K | FORM 10-K | 0001171843-23-001729 | 001-14027 | 23738582 | 34 | 10769783 | 1 | 1 | |
| 2023-03-14 | 4 | xslF345X03/ownership.xml | 0001171843-23-001686 | 9125 | ||||||
| 2023-03-14 | 4 | xslF345X03/ownership.xml | 0001171843-23-001685 | 9123 | ||||||
| 2023-03-14 | 4 | xslF345X03/ownership.xml | 0001171843-23-001684 | 10098 | ||||||
| 2023-03-10 | 4 | xslF345X03/ownership.xml | 0001171843-23-001597 | 13841 | ||||||
| 2023-03-10 | 4 | xslF345X03/ownership.xml | 0001171843-23-001596 | 13839 | ||||||
| 2023-03-10 | 4 | xslF345X03/ownership.xml | 0001171843-23-001595 | 15081 | ||||||
| 2023-03-07 | 4 | xslF345X03/ownership.xml | 0001171843-23-001480 | 9282 | ||||||
| 2023-03-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-23-001426 | 001-14027 | 23709025 | 34 | 360518 | 1 | 1 |
| 2023-02-21 | DFAN14A | ANIKA THERAPEUTICS, INC. | 0000902664-23-001925 | 001-14027 | 23646890 | 34 | 611386 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-037748 | 005-45573 | 23624147 | 34 | 70546 | |||
| 2023-02-10 | SC 13G/A | SEC SCHEDULE 13G | 0000354204-23-001495 | 005-45573 | 23610846 | 34 | 19521 | |||
| 2023-02-10 | SC 13G/A | SC 13G/A | 0001104659-23-018306 | 005-45573 | 23610154 | 34 | 119416 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015312 | 005-45573 | 23602424 | 34 | 13116 | |||
| 2023-02-08 | SC 13G/A | Anika_Therapeutics_Inc.txt | 0000093751-23-000340 | 005-45573 | 23597369 | 34 | 8579 | |||
| 2023-01-26 | SC 13G/A | us0352551081_012623.txt | 0001306550-23-004306 | 005-45573 | 23554550 | 34 | 13300 | |||
| 2023-01-20 | SC 13G | us0352551081_011923.txt | 0001306550-23-000614 | 005-45573 | 23539198 | 34 | 13267 | |||
| 2022-11-09 | 10-Q | FORM 10-Q | 0001171843-22-007281 | 001-14027 | 221372027 | 34 | 5959769 | 1 | 1 | |
| 2022-11-08 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-22-007233 | 001-14027 | 221368978 | 34 | 388653 | 1 | 1 |
| 2022-11-01 | 8-K | FORM 8-K | 8.01,9.01 | 0001171843-22-006969 | 001-14027 | 221351485 | 34 | 392794 | 1 | 1 |
| 2022-10-07 | SC 13G | SC 13G | 0001104659-22-106839 | 005-45573 | 221298903 | 34 | 96908 | |||
| 2022-08-11 | 4 | xslF345X03/ownership.xml | 0001171843-22-005617 | 7502 | ||||||
| 2022-08-05 | S-8 | FORM S-8 | 0001171843-22-005377 | 333-266550 | 221138009 | 33 | 56014 | |||
| 2022-08-04 | 10-Q | FORM 10-Q | 0001171843-22-005368 | 001-14027 | 221137522 | 34 | 6248102 | 1 | 1 | |
| 2022-08-03 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-22-005312 | 001-14027 | 221132664 | 34 | 420852 | 1 | 1 |
| 2022-06-10 | 4 | xslF345X03/ownership.xml | 0001171843-22-004302 | 4954 | ||||||
| 2022-06-10 | 4 | xslF345X03/ownership.xml | 0001171843-22-004301 | 4978 | ||||||
| 2022-06-10 | 4 | xslF345X03/ownership.xml | 0001171843-22-004300 | 4959 | ||||||
| 2022-06-10 | 4 | xslF345X03/ownership.xml | 0001171843-22-004299 | 4930 | ||||||
| 2022-06-10 | 4 | xslF345X03/ownership.xml | 0001171843-22-004298 | 4949 | ||||||
| 2022-06-10 | 4 | xslF345X03/ownership.xml | 0001171843-22-004297 | 4922 | ||||||
| 2022-06-10 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001171843-22-004296 | 001-14027 | 221008838 | 34 | 401994 | 1 | 1 |
| 2022-06-09 | SC 13G/A | NONE | 0001567619-22-012601 | 005-45573 | 221006150 | 34 | 66352 | |||
| 2022-06-03 | DEFA14A | DEFA14A | 0001171843-22-004116 | 001-14027 | 22993047 | 34 | 17337 | |||
| 2022-06-01 | DEFA14A | FORM DEFA14A | 0001171843-22-004066 | 001-14027 | 22986595 | 34 | 1260605 | |||
| 2022-06-01 | DEFR14A | DEFR14A | 0001171843-22-004065 | 001-14027 | 22986577 | 34 | 31960 | |||
| 2022-05-12 | 4 | xslF345X03/ownership.xml | 0001171843-22-003615 | 4561 | ||||||
| 2022-05-09 | DEFA14A | DEFA14A | 0001171843-22-003457 | 001-14027 | 22904764 | 34 | 3143050 | |||
| 2022-05-06 | 10-Q | FORM 10-Q | 0001171843-22-003350 | 001-14027 | 22897954 | 34 | 5529971 | 1 | 1 | |
| 2022-05-05 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-22-003332 | 001-14027 | 22896324 | 34 | 333350 | 1 | 1 |
| 2022-04-28 | 4 | xslF345X03/ownership.xml | 0001171843-22-002980 | 8284 | ||||||
| 2022-04-27 | DEF 14A | DEF 14A | 0001171843-22-002875 | 001-14027 | 22860705 | 34 | 1780308 | |||
| 2022-04-27 | DEFA14A | DEFA14A | 0001171843-22-002876 | 001-14027 | 22860701 | 34 | 206770 | |||
| 2022-03-16 | 4 | xslF345X03/ownership.xml | 0001171843-22-001915 | 5082 | ||||||
| 2022-03-15 | 4 | xslF345X03/ownership.xml | 0001171843-22-001906 | 7864 | ||||||
| 2022-03-15 | 4 | xslF345X03/ownership.xml | 0001171843-22-001905 | 7866 | ||||||
| 2022-03-15 | 4 | xslF345X03/ownership.xml | 0001171843-22-001903 | 7865 | ||||||
| 2022-03-15 | 4 | xslF345X03/ownership.xml | 0001171843-22-001878 | 5037 | ||||||
| 2022-03-14 | 4 | xslF345X03/ownership.xml | 0001171843-22-001833 | 7051 | ||||||
| 2022-03-14 | 4 | xslF345X03/ownership.xml | 0001171843-22-001832 | 5081 | ||||||
| 2022-03-11 | 4 | xslF345X03/ownership.xml | 0001171843-22-001812 | 7307 | ||||||
| 2022-03-11 | 4 | xslF345X03/ownership.xml | 0001171843-22-001811 | 9041 | ||||||
| 2022-03-11 | 4 | xslF345X03/ownership.xml | 0001171843-22-001810 | 9085 | ||||||
| 2022-03-11 | 4 | xslF345X03/ownership.xml | 0001171843-22-001809 | 7311 | ||||||
| 2022-03-11 | 10-K | FORM 10-K | 0001171843-22-001790 | 001-14027 | 22730751 | 34 | 25952384 | 1 | 1 | |
| 2022-03-08 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-22-001706 | 001-14027 | 22722265 | 34 | 411832 | 1 | 1 |
| 2022-03-07 | 4 | xslF345X03/ownership.xml | 0001171843-22-001664 | 9083 | ||||||
| 2022-02-28 | 4 | xslF345X03/ownership.xml | 0001171843-22-001459 | 14770 | ||||||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001193125-22-040700 | 005-45573 | 22628071 | 34 | 69127 | |||
| 2022-02-14 | SC 13G/A | d9177681_13g-a.htm | 0000919574-22-001038 | 005-45573 | 22623636 | 34 | 165119 | |||
| 2022-02-14 | SC 13G/A | NONE | 0001567619-22-003727 | 005-45573 | 22623478 | 34 | 66361 | |||
| 2022-02-11 | 4 | xslF345X03/ownership.xml | 0001171843-22-000984 | 6912 | ||||||
| 2022-02-10 | SC 13G/A | anik-13g_20211231.txt | 0001037389-22-000010 | 005-45573 | 22613480 | 34 | 13482 | |||
| 2022-02-10 | SC 13G/A | ANIKA_THERAPEUTICS_INC.txt | 0000093751-22-000145 | 005-45573 | 22613164 | 34 | 8584 | |||
| 2022-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-016488 | 005-45573 | 22606361 | 34 | 13112 | |||
| 2022-02-08 | SC 13G/A | SEC SCHEDULE 13G | 0000354204-22-001660 | 005-45573 | 22601190 | 34 | 19520 | |||
| 2022-01-27 | SC 13G/A | us0352551081_012722.txt | 0000834237-22-002382 | 005-45573 | 22562379 | 34 | 13271 | |||
| 2022-01-26 | SC 13G | us0352551081_012522.txt | 0000834237-22-000902 | 005-45573 | 22555255 | 34 | 13262 | |||
| 2021-11-15 | 8-K | FORM 8-K | 1.01,2.03,9.01 | 0001171843-21-007914 | 001-14027 | 211406412 | 34 | 2024252 | 1 | 1 |
| 2021-11-05 | S-8 | FORM S-8 | 0001171843-21-007627 | 333-260821 | 211384505 | 33 | 60706 | |||
| 2021-11-05 | 10-Q | FORM 10-Q | 0001171843-21-007580 | 001-14027 | 211381439 | 34 | 6632661 | 1 | 1 | |
| 2021-11-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-21-007565 | 001-14027 | 211380064 | 34 | 405655 | 1 | 1 |
| 2021-11-01 | 4 | xslF345X03/ownership.xml | 0001171843-21-007368 | 4891 | ||||||
| 2021-11-01 | 3 | xslF345X02/ownership.xml | 0001171843-21-007367 | 9509 | ||||||
| 2021-11-01 | 8-K | FORM 8-K | 5.02,7.01,9.01 | 0001171843-21-007366 | 001-14027 | 211368434 | 34 | 224255 | 1 | 1 |
| 2021-08-13 | 4 | xslF345X03/ownership.xml | 0001171843-21-005933 | 7041 | ||||||
| 2021-08-12 | 4 | xslF345X03/ownership.xml | 0001171843-21-005897 | 7286 | ||||||
| 2021-08-06 | S-8 | S-8 | 0001171843-21-005596 | 333-258530 | 211149838 | 33 | 60850 | |||
| 2021-08-06 | S-8 | S-8 | 0001171843-21-005595 | 333-258529 | 211149835 | 33 | 43264 | |||
| 2021-08-06 | 10-Q | FORM 10-Q | 0001171843-21-005594 | 001-14027 | 211149832 | 34 | 5616470 | 1 | 1 | |
| 2021-08-05 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-21-005577 | 001-14027 | 211148289 | 34 | 367977 | 1 | 1 |
| 2021-07-12 | 4 | xslF345X03/ownership.xml | 0001171843-21-004833 | 8834 | ||||||
| 2021-06-30 | 8-K | FORM 8-K | 8.01 | 0001171843-21-004630 | 001-14027 | 211062780 | 34 | 188824 | 1 | 1 |
| 2021-06-22 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001171843-21-004469 | 001-14027 | 211035531 | 34 | 474528 | 1 | 1 |
| 2021-06-21 | 4 | xslF345X03/ownership.xml | 0001171843-21-004431 | 4955 | ||||||
| 2021-06-21 | 4 | xslF345X03/ownership.xml | 0001171843-21-004430 | 4923 | ||||||
| 2021-06-21 | 4 | xslF345X03/ownership.xml | 0001171843-21-004429 | 4951 | ||||||
| 2021-06-21 | 4 | xslF345X03/ownership.xml | 0001171843-21-004428 | 4960 | ||||||
| 2021-06-21 | 4 | xslF345X03/ownership.xml | 0001171843-21-004427 | 4812 | ||||||
| 2021-06-21 | 4 | xslF345X03/ownership.xml | 0001171843-21-004426 | 4931 | ||||||
| 2021-06-17 | 4 | xslF345X03/ownership.xml | 0001171843-21-004397 | 6889 | ||||||
| 2021-05-20 | 4 | xslF345X03/ownership.xml | 0001171843-21-003679 | 5042 | ||||||
| 2021-05-14 | 4 | xslF345X03/ownership.xml | 0001171843-21-003534 | 4906 | ||||||
| 2021-05-07 | 10-Q | FORM 10-Q | 0001171843-21-003272 | 001-14027 | 21899259 | 34 | 5413983 | 1 | 1 | |
| 2021-05-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-21-003263 | 001-14027 | 21897851 | 34 | 314737 | 1 | 1 |
| 2021-04-30 | DEFA14A | DEFA14A | 0001171843-21-002977 | 001-14027 | 21878606 | 34 | 194678 | |||
| 2021-04-30 | DEF 14A | DEF 14A | 0001171843-21-002976 | 001-14027 | 21878475 | 34 | 1973780 | |||
| 2021-04-28 | 4 | xslF345X03/ownership.xml | 0001171843-21-002890 | 7284 | ||||||
| 2021-04-26 | 10-K/A | FORM 10-K/A | 0001171843-21-002766 | 001-14027 | 21854732 | 34 | 10904285 | 1 | 1 | |
| 2021-03-11 | 4 | xslF345X03/ownership.xml | 0001171843-21-001712 | 7841 | ||||||
| 2021-03-11 | 4 | xslF345X03/ownership.xml | 0001171843-21-001711 | 7864 | ||||||
| 2021-03-11 | 4 | xslF345X03/ownership.xml | 0001171843-21-001710 | 7818 | ||||||
| 2021-03-11 | 4 | xslF345X03/ownership.xml | 0001171843-21-001709 | 7862 | ||||||
| 2021-03-11 | 4 | xslF345X03/ownership.xml | 0001171843-21-001708 | 7863 | ||||||
| 2021-03-08 | 4 | xslF345X03/ownership.xml | 0001171843-21-001598 | 7100 | ||||||
| 2021-03-05 | 10-K | FORM 10-K | 0001171843-21-001573 | 001-14027 | 21719601 | 34 | 11698763 | 1 | 1 | |
| 2021-03-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-21-001546 | 001-14027 | 21714244 | 34 | 434257 | 1 | 1 |
| 2021-03-01 | 4 | xslF345X03/ownership.xml | 0001171843-21-001429 | 7511 | ||||||
| 2021-03-01 | 4 | xslF345X03/ownership.xml | 0001171843-21-001428 | 14949 | ||||||
| 2021-02-16 | SC 13G | d8798973_13-g.htm | 0000919574-21-001359 | 005-45573 | 21634702 | 34 | 169895 | |||
| 2021-02-12 | SC 13G/A | SEC SCHEDULE 13G | 0000354204-21-000284 | 005-45573 | 21626872 | 34 | 19529 | |||
| 2021-02-12 | SC 13G | SC 13G | 0001193125-21-040398 | 005-45573 | 21623504 | 34 | 73761 | |||
| 2021-02-11 | SC 13G/A | NONE | 0001567619-21-002826 | 005-45573 | 21615385 | 34 | 66369 | |||
| 2021-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-017444 | 005-45573 | 21609996 | 34 | 13983 | |||
| 2021-02-10 | SC 13G | anik-13g_20201231.txt | 0001037389-21-000005 | 005-45573 | 21609678 | 34 | 13449 | |||
| 2021-02-05 | SC 13G | Anika_Therapeutics_Inc.txt | 0000093751-21-000074 | 005-45573 | 21594621 | 34 | 8556 | |||
| 2021-01-25 | SC 13G/A | us0352551081_012521.txt | 0000834237-21-000670 | 005-45573 | 21550496 | 34 | 13247 | |||
| 2020-11-12 | 4 | xslF345X03/ownership.xml | 0001171843-20-007934 | 4908 | ||||||
| 2020-11-05 | 10-Q | FORM 10-Q | 0001171843-20-007600 | 001-14027 | 201288122 | 34 | 7835278 | 1 | 1 | |
| 2020-11-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-20-007581 | 001-14027 | 201286794 | 34 | 412461 | 1 | 1 |
| 2020-11-03 | 4 | xslF345X03/ownership.xml | 0001171843-20-007517 | 5070 | ||||||
| 2020-10-21 | 8-K | FORM 8-K | 8.01,9.01 | 0001171843-20-007136 | 001-14027 | 201250654 | 34 | 229838 | 1 | 1 |
| 2020-09-08 | 4 | xslF345X03/ownership.xml | 0001171843-20-006337 | 4993 | ||||||
| 2020-09-08 | 4 | xslF345X03/ownership.xml | 0001171843-20-006336 | 4983 | ||||||
| 2020-09-08 | 3 | xslF345X02/ownership.xml | 0001171843-20-006335 | 3068 | ||||||
| 2020-09-08 | 3 | xslF345X02/ownership.xml | 0001171843-20-006334 | 3047 | ||||||
| 2020-09-08 | 8-K | FORM 8-K | 5.02,7.01,9.01 | 0001171843-20-006332 | 001-14027 | 201164907 | 34 | 242535 | 1 | 1 |
| 2020-08-17 | SC 13G/A | NONE | 0001567619-20-015623 | 005-45573 | 201109670 | 34 | 66365 | |||
| 2020-08-12 | 4 | xslF345X03/ownership.xml | 0001171843-20-005857 | 7681 | ||||||
| 2020-08-12 | 3 | xslF345X02/ownership.xml | 0001171843-20-005856 | 3026 | ||||||
| 2020-08-07 | 10-Q | FORM 10-Q | 0001171843-20-005715 | 001-14027 | 201084027 | 34 | 7547858 | 1 | 1 | |
| 2020-08-06 | 10-Q/A | FORM 10-Q/A | 0001171843-20-005655 | 001-14027 | 201081549 | 34 | 40404 | |||
| 2020-08-05 | 8-K | FORM 8-K | 5.02,7.01,9.01 | 0001171843-20-005566 | 001-14027 | 201078455 | 34 | 98157 | ||
| 2020-08-05 | SC 13G/A | NONE | 0001567619-20-014322 | 005-45573 | 201078026 | 34 | 66365 | |||
| 2020-07-30 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-20-005415 | 001-14027 | 201061510 | 34 | 189199 | ||
| 2020-07-10 | 4 | xslF345X03/ownership.xml | 0001171843-20-004894 | 6590 | ||||||
| 2020-06-19 | S-8 | S-8 | 0001171843-20-004454 | 333-239304 | 20975667 | 33 | 45263 | |||
| 2020-06-18 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001171843-20-004425 | 001-14027 | 20972501 | 34 | 198706 | ||
| 2020-06-02 | 8-K | FORM 8-K | 5.02,7.01,9.01 | 0001171843-20-004133 | 001-14027 | 20936970 | 34 | 18454 | ||
| 2020-05-22 | 10-Q | FORM 10-Q | 0001171843-20-003962 | 001-14027 | 20906728 | 34 | 4984700 | 1 | ||
| 2020-05-08 | 8-K | FORM 8-K | 8.01 | 0001171843-20-003513 | 001-14027 | 20858090 | 34 | 26552 | ||
| 2020-05-07 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-20-003473 | 001-14027 | 20856301 | 34 | 131558 | ||
| 2020-04-29 | 8-K | FORM 8-K | 1.01,5.02,7.01,9.01 | 0001171843-20-003020 | 001-14027 | 20830484 | 34 | 150694 | ||
| 2020-04-29 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001171843-20-003017 | 001-14027 | 20830368 | 34 | 4284925 | |||
| 2020-04-29 | DEF 14A | DEF 14A | 0001171843-20-003014 | 001-14027 | 20830232 | 34 | 1642541 | |||
| 2020-04-28 | 4 | xslF345X03/ownership.xml | 0001171843-20-002971 | 11437 | ||||||
| 2020-04-08 | 8-K | FORM 8-K | 2.03,9.01 | 0001171843-20-002483 | 001-14027 | 20782063 | 34 | 23703 | ||
| 2020-03-13 | 8-K/A | FORM 8-K/A | 9.01 | 0001171843-20-001713 | 001-14027 | 20712645 | 34 | 800603 | ||
| 2020-03-13 | 8-K/A | FORM 8-K/A | 9.01 | 0001171843-20-001712 | 001-14027 | 20712640 | 34 | 355256 | ||
| 2020-03-06 | 4 | xslF345X03/ownership.xml | 0001171843-20-001547 | 7671 | ||||||
| 2020-03-06 | 3 | xslF345X02/ownership.xml | 0001171843-20-001546 | 3023 | ||||||
| 2020-03-06 | 10-K | FORM 10-K | 0001171843-20-001536 | 001-14027 | 20692468 | 34 | 6631369 | 1 | ||
| 2020-03-02 | 8-K | FORM 8-K | 5.02,9.01 | 0001171843-20-001415 | 001-14027 | 20676786 | 34 | 54634 | ||
| 2020-02-27 | 4 | xslF345X03/ownership.xml | 0001171843-20-001364 | 6687 | ||||||
| 2020-02-27 | 4 | xslF345X03/ownership.xml | 0001171843-20-001363 | 9042 | ||||||
| 2020-02-27 | 4 | xslF345X03/ownership.xml | 0001171843-20-001362 | 5636 | ||||||
| 2020-02-27 | 4 | xslF345X03/ownership.xml | 0001171843-20-001361 | 4882 | ||||||
| 2020-02-27 | 4 | xslF345X03/ownership.xml | 0001171843-20-001360 | 4887 | ||||||
| 2020-02-27 | 4 | xslF345X03/ownership.xml | 0001171843-20-001359 | 5118 | ||||||
| 2020-02-27 | 4 | xslF345X03/ownership.xml | 0001171843-20-001358 | 9073 | ||||||
| 2020-02-27 | 4 | xslF345X03/ownership.xml | 0001171843-20-001357 | 6236 | ||||||
| 2020-02-27 | 4 | xslF345X03/ownership.xml | 0001171843-20-001356 | 4850 | ||||||
| 2020-02-20 | 8-K | FORM 8-K | 2.02,9.01 | 0001171843-20-001133 | 001-14027 | 20635055 | 34 | 217650 | ||
| 2020-02-19 | SEC STAFF LETTER | filename1.pdf | 9999999997-20-000800 | 227620 | ||||||
| 2020-02-14 | 8-K | FORM 8-K | 5.02,7.01,9.01 | 0001171843-20-000991 | 001-14027 | 20619409 | 34 | 25839 | ||
| 2020-02-14 | SC 13G/A | NONE | 0001567619-20-003430 | 005-45573 | 20612675 | 34 | 66368 | |||
| 2020-02-13 | SC 13G | AnikaTherapeuticsInc.txt | 0000093751-20-000414 | 005-45573 | 20608564 | 34 | 8672 | |||
| 2020-02-12 | SC 13G/A | SCHEDULE 13G/A | 0001104659-20-018686 | 005-45573 | 20601719 | 34 | 13802 | |||
| 2020-02-12 | SC 13G/A | SCHEDULE 13G/A | 0001258897-20-000780 | 005-45573 | 20600967 | 34 | 53082 | |||
| 2020-02-06 | 4 | xslF345X03/ownership.xml | 0001171843-20-000783 | 5102 | ||||||
| 2020-02-04 | SC 13G/A | us0352551081_020320.txt | 0000834237-20-001600 | 005-45573 | 20571430 | 34 | 13285 | |||
| 2020-02-03 | 8-K | FORM 8-K | 2.01,8.01,9.01 | 0001171843-20-000664 | 001-14027 | 20569047 | 34 | 26917 | ||
| 2020-01-31 | SEC STAFF LETTER | filename1.pdf | 9999999997-20-000410 | 230927 | ||||||
| 2020-01-30 | 8-K | FORM 8-K | 5.02,7.01,9.01 | 0001171843-20-000604 | 001-14027 | 20561423 | 34 | 24640 | ||
| 2020-01-24 | 8-K | FORM 8-K | 2.01,8.01,9.01 | 0001171843-20-000472 | 001-14027 | 20545479 | 34 | 25567 | ||
| 2020-01-07 | 8-K | FORM 8-K | 1.01,9.01 | 0001171843-20-000105 | 001-14027 | 20513375 | 34 | 1256000 | ||
| 2020-01-06 | 8-K | ANIKA THERAPEUTICS, INC. 8-K | 8.01,9.01 | 0001157523-20-000024 | 001-14027 | 20510717 | 34 | 40014 | ||
| 2019-11-29 | 4 | xslF345X03/ownership.xml | 0001171843-19-007869 | 5023 | ||||||
| 2019-11-08 | 4 | xslF345X03/ownership.xml | 0001171843-19-007390 | 11102 | ||||||
| 2019-11-01 | 4 | xslF345X03/ownership.xml | 0001171843-19-007081 | 5011 | ||||||
| 2019-10-28 | 10-Q | FORM 10-Q | 0001171843-19-006886 | 001-14027 | 191173881 | 34 | 3819921 | 1 | ||
| 2019-10-25 | 8-K | ANIKA THERAPEUTICS, INC. 8-K | 2.02,9.01 | 0001157523-19-002103 | 001-14027 | 191166675 | 34 | 307403 | ||
| 2019-08-30 | 4 | xslF345X03/ownership.xml | 0001171843-19-005733 | 4938 | ||||||
| 2019-08-22 | 4 | xslF345X03/ownership.xml | 0001171843-19-005617 | 4976 | ||||||
| 2019-08-12 | 4 | xslF345X03/ownership.xml | 0001171843-19-005414 | 4900 | ||||||
| 2019-07-30 | 4 | xslF345X03/ownership.xml | 0001171843-19-004979 | 4623 | ||||||
| 2019-07-30 | 4 | xslF345X03/ownership.xml | 0001171843-19-004978 | 5038 | ||||||
| 2019-07-26 | 10-Q | FORM 10-Q | 0001171843-19-004913 | 001-14027 | 19978592 | 34 | 3595913 | 1 | ||
| 2019-07-24 | 8-K | ANIKA THERAPEUTICS, INC. 8-K | 2.02,9.01 | 0001157523-19-001572 | 001-14027 | 19971001 | 34 | 309184 | ||
| 2019-07-10 | 8-K | FORM 8-K | 5.02 | 0001171843-19-004502 | 001-14027 | 19949395 | 34 | 134463 | ||
| 2019-07-09 | 4 | xslF345X03/ownership.xml | 0001171843-19-004474 | 7651 | ||||||
| 2019-07-09 | 3 | xslF345X02/ownership.xml | 0001171843-19-004473 | 210680 | ||||||
| 2019-06-26 | 8-K | FORM 8-K | 5.02 | 0001171843-19-004182 | 001-14027 | 19921669 | 34 | 14923 | ||
| 2019-06-21 | S-8 | FORM S-8 | 0001171843-19-004107 | 333-232254 | 19911579 | 33 | 48195 | |||
| 2019-06-20 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001171843-19-004087 | 001-14027 | 19908605 | 34 | 189521 | ||
| 2019-05-13 | 8-K | FORM 8-K | 1.01,8.01 | 0001171843-19-003311 | 001-14027 | 19818418 | 34 | 21349 | ||
| 2019-05-06 | 10-Q | FORM 10-Q | 0001171843-19-002946 | 001-14027 | 19797709 | 34 | 2957468 | 1 | ||
| 2019-05-02 | 8-K | ANIKA THERAPEUTICS, INC. 8-K | 2.02,9.01 | 0001157523-19-001056 | 001-14027 | 19791898 | 34 | 106780 | ||
| 2019-04-25 | DEFA14A | DEFA14A | 0001171843-19-002642 | 001-14027 | 19767535 | 34 | 978494 | |||
| 2019-04-25 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001171843-19-002640 | 001-14027 | 19767429 | 34 | 1738808 | |||
| 2019-04-12 | 8-K | FORM 8-K | 5.02,9.01 | 0001171843-19-002383 | 001-14027 | 19746320 | 34 | 236078 | ||
| 2019-03-26 | 8-K | FORM 8-K | 5.02 | 0001171843-19-001983 | 001-14027 | 19705344 | 34 | 16308 | ||
| 2019-03-01 | 4 | xslF345X03/ownership.xml | 0001171843-19-001414 | 4552 | ||||||
| 2019-02-28 | 4 | xslF345X03/ownership.xml | 0001171843-19-001392 | 4881 | ||||||
| 2019-02-28 | 4 | xslF345X03/ownership.xml | 0001171843-19-001391 | 4850 | ||||||
| 2019-02-28 | 4 | xslF345X03/ownership.xml | 0001171843-19-001390 | 4887 | ||||||
| 2019-02-28 | 4 | xslF345X03/ownership.xml | 0001171843-19-001389 | 6691 | ||||||
| 2019-02-28 | 4 | xslF345X03/ownership.xml | 0001171843-19-001388 | 8349 | ||||||
| 2019-02-28 | 4 | xslF345X03/ownership.xml | 0001171843-19-001387 | 8360 | ||||||
| 2019-02-28 | 4 | xslF345X03/ownership.xml | 0001171843-19-001386 | 8705 | ||||||
| 2019-02-28 | 4 | xslF345X03/ownership.xml | 0001171843-19-001385 | 8386 | ||||||
| 2019-02-28 | 4 | xslF345X03/ownership.xml | 0001171843-19-001384 | 4837 | ||||||
| 2019-02-28 | 4 | xslF345X03/ownership.xml | 0001171843-19-001383 | 4869 | ||||||
| 2019-02-28 | 4 | xslF345X03/ownership.xml | 0001171843-19-001382 | 8409 | ||||||
| 2019-02-27 | 10-K | FORM 10-K | 0001171843-19-001243 | 001-14027 | 19635510 | 34 | 6361140 | 1 | ||
| 2019-02-21 | 8-K | ANIKA THERAPEUTICS, INC. 8-K | 2.02,9.01 | 0001157523-19-000413 | 001-14027 | 19621863 | 34 | 155183 | ||
| 2019-02-12 | SC 13G/A | NONE | 0001567619-19-003279 | 005-45573 | 19591327 | 34 | 66370 | |||
| 2019-02-12 | SC 13G/A | SEC SCHEDULE 13G | 0000902219-19-000124 | 005-45573 | 19588079 | 34 | 33101 | |||
| 2019-02-11 | SC 13G/A | anikatherapeuticsinc.htm | 0000932471-19-004316 | 005-45573 | 19582075 | 34 | 34292 | |||
| 2019-02-08 | SC 13G/A | SCHEDULE 13G/A | 0001258897-19-001335 | 005-45573 | 19577876 | 34 | 53142 |
One latest value per concept from companyfacts (470 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 13.40M | 2026-10-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 147.34M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| ecd | CoSelectedMeasureAmt | CoSelectedMeasureAmt | USD | 113.00M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017488 | ||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 645,195 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017488 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.34M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017488 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 120 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017488 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 2.08M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017488 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 4.89M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017488 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 21 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001140361-26-017488 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 1,066.04 | 2026-07-28 | S-8 | 2026-07-29 | 0001171843-26-005017 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 1,066.04 | 2026-07-28 | S-8 | 2026-07-29 | 0001171843-26-005017 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 7.72M | 2026-07-28 | S-8 | 2026-07-29 | 0001171843-26-005017 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-07-28 | S-8 | 2026-07-29 | 0001171843-26-005017 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 6.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | AccountsReceivableGrossCurrent | Accounts Receivable, before Allowance for Credit Loss, Current | USD | 24.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 24.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 20.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 7.96M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001171843-18-003806 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 1.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | AccruedRentCurrent | Accrued Rent, Current | USD | 231,000 | 2016-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001171843-18-001450 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 1.82M | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-04 | 0001171843-14-003693 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 55.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax | USD | -6.07M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-03 | 0001171843-15-005922 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -5.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 67.39M | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-06 | 0001157523-13-003914 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 84.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 27,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 11.68M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001171843-25-001486 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation | USD | 647,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001171843-19-001243 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 12.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 640,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableChargeOffs | Allowance for Doubtful Accounts Receivable, Charge-offs (Deprecated 2013-01-31) | USD | 135,353 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001157523-13-001397 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 640,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableRecoveries | Accounts Receivable, Allowance for Credit Loss, Recovery | USD | 369,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableWriteOffs | Accounts Receivable, Allowance for Credit Loss, Writeoff | USD | 417,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | AmortizationOfAcquiredIntangibleAssets | Amortization of Acquired Intangible Assets (Deprecated 2013-01-31) | USD | 519,982 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-06 | 0001157523-13-002386 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | -25,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K/A | 2021-04-26 | 0001171843-21-002766 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 400,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 1.10M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-03-15 | 0001171843-24-001380 |
| us-gaap | AreaOfLand | Area of Land | sqft | 26,000 | 2009-12-30 | 2013 | Q2 | 10-Q | 2013-08-06 | 0001157523-13-003914 | |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2020-07-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001171843-20-007600 |
| us-gaap | Assets | Assets | USD | 189.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 103.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | AssetsOfDisposalGroupIncludingDiscontinuedOperation | Disposal Group, Including Discontinued Operation, Assets | USD | 7.15M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Assets, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 22.01M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-03 | 0001171843-15-005922 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 699 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001171843-14-005281 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax | USD | 0 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-10-26 | 0001171843-18-007266 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 1,391 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-03 | 0001171843-15-005922 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 22.01M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-03 | 0001171843-15-005922 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | BusinessAcquisitionsProFormaNetIncomeLoss | Business Acquisition, Pro Forma Net Income (Loss) | USD | -22.98M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0001171843-23-001729 |
| us-gaap | BusinessAcquisitionsProFormaRevenue | Business Acquisition, Pro Forma Revenue | USD | 134.41M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0001171843-23-001729 |
| us-gaap | BusinessCombinationAcquisitionRelatedCosts | Business Combination, Acquisition Related Costs | USD | 2.15M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-03-13 | 0001157523-12-001365 |
| us-gaap | BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-15 | 0001171843-24-001380 |
| us-gaap | BusinessCombinationContingentConsiderationLiability | Business Combination, Contingent Consideration, Liability | USD | 16.90M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-06 | 0001171843-21-005594 | |
| us-gaap | BusinessCombinationContingentConsiderationLiabilityCurrent | Business Combination, Contingent Consideration, Liability, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0001171843-23-001729 | |
| us-gaap | BusinessCombinationContingentConsiderationLiabilityNoncurrent | Business Combination, Contingent Consideration, Liability, Noncurrent | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-11 | 0001171843-22-001790 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 918,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | CapitalizedComputerSoftwareAccumulatedAmortization | Capitalized Computer Software, Accumulated Amortization | USD | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-04 | 0001171843-24-005993 | |
| us-gaap | CapitalLeaseObligationsIncurred | Lease Obligation Incurred | USD | 220,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-05 | 0001171843-21-007580 |
| us-gaap | CashAcquiredFromAcquisition | Cash Acquired from Acquisition | USD | 105,300 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001157523-13-001397 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 44.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 6.39M | 2017-12-31 | 2018 | Q3 | 10-Q | 2018-10-26 | 0001171843-18-007266 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -91.63M | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-22 | 0001171843-20-003962 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 44.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -12.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | CertificatesOfDepositAtCarryingValue | Certificates of Deposit, at Carrying Value | USD | 5.50M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001171843-20-007600 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 90.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 15.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 13.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 134,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -2.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | ConcentrationRiskPercentage1 | Concentration Risk, Percentage | pure | 1 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001171843-18-001450 |
| us-gaap | ConstructionInProgressGross | Construction in Progress, Gross | USD | 22.70M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001171843-17-001121 | |
| us-gaap | ConstructionPayableCurrent | Construction Payable, Current | USD | 804,000 | 2016-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001171843-18-001450 | |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 261,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 33.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | CostOfGoodsSold | Cost of Goods Sold (Deprecated 2018-01-31) | USD | 27.36M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001171843-18-001450 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 62.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) | USD | 248,000 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 | |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 176,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 250,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 611,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 185,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | DebtInstrumentBasisSpreadOnVariableRate1 | Debt Instrument, Basis Spread on Variable Rate | pure | 0.013 | 2013-01-01 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-05 | 0001171843-13-004422 |
| us-gaap | DebtInstrumentInterestRateAtPeriodEnd | Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) | pure | 0.014 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-05 | 0001171843-13-004422 | |
| us-gaap | DebtIssuanceCosts | Debt Issuance Cost (Deprecated 2016-01-31) | USD | 74,000 | 2008-02-01 | 2008-12-31 | 2013 | FY | 10-K | 2014-03-13 | 0001171843-14-001240 |
| us-gaap | DeferredCompensationShareBasedArrangementsLiabilityCurrent | Deferred Compensation Share-based Arrangements, Liability, Current | USD | 7.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNet | Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Net | USD | 171,000 | 2008-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001157523-13-001397 | |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 61,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | DeferredIncomeTaxAssetsNet | Deferred Income Tax Assets, Net | USD | 925,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 329,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 12.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredIncomeTaxLiabilitiesNet | Deferred Income Tax Liabilities, Net | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-15 | 0001171843-24-001380 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 126,702 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001171843-15-001395 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 33,948 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-03 | 0001171843-15-005922 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 48,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001171843-17-001121 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | DeferredTaxAssetsCapitalLossCarryforwards | Deferred Tax Assets, Capital Loss Carryforwards | USD | 19.99M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 23,854 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001171843-15-001395 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 776,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 59.02M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredTaxAssetsInventory | Deferred Tax Assets, Inventory | USD | 1.56M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 1.27M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 13.44M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredTaxAssetsNetCurrent | Deferred Tax Assets, Net of Valuation Allowance, Current | USD | 1.41M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-03 | 0001171843-15-005922 | |
| us-gaap | DeferredTaxAssetsNetNoncurrent | Deferred Tax Assets, Net of Valuation Allowance, Noncurrent | USD | 392,005 | 2010-12-31 | 2011 | FY | 10-K | 2012-03-13 | 0001157523-12-001365 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 13.29M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsForeign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | USD | 1.81M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 515,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-15 | 0001171843-24-001380 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation | USD | 1.18M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 3.63M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 819,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredTaxAssetsUnrealizedCurrencyLosses | Deferred Tax Assets, Unrealized Currency Losses | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 45.58M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredTaxExpenseFromStockOptionsExercised | Deferred Tax Expense from Stock Options Exercised | USD | 4.44M | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-05 | 0001171843-14-002144 |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 4.99M | 2022-12-31 | 2023 | FY | 10-K | 2024-03-15 | 0001171843-24-001380 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssets | Deferred Tax Liabilities, Goodwill and Intangible Assets | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DeferredTaxLiabilitiesNoncurrent | Deferred Tax Liabilities, Net, Noncurrent | USD | 4.73M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-10-28 | 0001171843-19-006886 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 6.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 362,150 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-13 | 0001171843-14-001240 |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 600,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001171843-17-001121 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercent | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | pure | 0.05 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | Depreciation | Depreciation | USD | 4.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 4.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 2.27M | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-06 | 0001157523-13-003914 |
| us-gaap | DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax | Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | DiscontinuedOperationTaxEffectOfDiscontinuedOperation | Discontinued Operation, Tax Effect of Discontinued Operation | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet | Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net | USD | 3.29M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent | Disposal Group, Including Discontinued Operation, Accounts Payable, Current | USD | 797,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent | Disposal Group, Including Discontinued Operation, Assets, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents | Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents | USD | 1.53M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold | Disposal Group, Including Discontinued Operation, Costs of Goods Sold | USD | 3.63M | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-09 | 0001171843-25-003019 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationInventory1 | Disposal Group, Including Discontinued Operation, Inventory | USD | 221,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities | Disposal Group, Including Discontinued Operation, Other Liabilities, Current | USD | 3.32M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets | Disposal Group, Including Discontinued Operation, Prepaid and Other Assets | USD | 89,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment | Disposal Group, Including Discontinued Operation, Property, Plant and Equipment | USD | 1.13M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationRevenue | Disposal Group, Including Discontinued Operation, Revenue | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | DueToRelatedPartiesCurrentAndNoncurrent | Due to Related Parties | USD | 700,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001157523-13-001397 | |
| us-gaap | EarlyRepaymentOfSeniorDebt | Early Repayment of Senior Debt | USD | 8.40M | 2013-11-01 | 2013-11-30 | 2013 | FY | 10-K | 2014-03-13 | 0001171843-14-001240 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.15 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.15 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.167 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 |
| us-gaap | EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent | pure | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | -0.002 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 |
| us-gaap | EffectiveIncomeTaxRateReconciliationGiltiAmount | EffectiveIncomeTaxRateReconciliationGiltiAmount | USD | 371,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | EffectiveIncomeTaxRateReconciliationGiltiPercent | EffectiveIncomeTaxRateReconciliationGiltiPercent | pure | -0.04 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.003 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-10 | 0001171843-16-008487 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.005 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | 0.014 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent | pure | -0.064 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 400,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-10-28 | 0001171843-19-006886 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.117 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.022 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.013 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-15 | 0001171843-24-001380 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsForeign | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent | pure | 0.025 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001157523-13-001397 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment | Effective Income Tax Rate Reconciliation, Tax Credit, Investment, Percent | pure | 0.001 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.045 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalents | Effect of Exchange Rate on Cash and Cash Equivalents | USD | -31,000 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-22 | 0001171843-20-003962 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | -21,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 8.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 5.50M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001171843-25-001486 | |
| us-gaap | EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense | Share-based Payment Arrangement, Expense, Tax Benefit | USD | 800,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | ExcessTaxBenefitFromShareBasedCompensationFinancingActivities | Excess Tax Benefit from Share-based Compensation, Financing Activities | USD | 647,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001171843-17-001121 |
| us-gaap | ExcessTaxBenefitFromShareBasedCompensationOperatingActivities | Excess Tax Benefit from Share-based Compensation, Operating Activities | USD | 647,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001171843-17-001121 |
| us-gaap | FinanceLeaseInterestExpense | Finance Lease, Interest Expense | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-15 | 0001171843-24-001380 |
| us-gaap | FinanceLeaseInterestPaymentOnLiability | Finance Lease, Interest Payment on Liability | USD | 22,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001171843-20-007600 |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 2.49M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-05 | 0001171843-21-007580 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 356,000 | 2020-12-31 | 2020 | FY | 10-K/A | 2021-04-26 | 0001171843-21-002766 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueAfterYearFive | Finance Lease, Liability, to be Paid, after Year Five | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-11 | 0001171843-22-001790 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueNextTwelveMonths | Finance Lease, Liability, to be Paid, Year One | USD | 132,000 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001171843-22-005368 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFive | Finance Lease, Liability, to be Paid, Year Five | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-11 | 0001171843-22-001790 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFour | Finance Lease, Liability, to be Paid, Year Four | USD | 0 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001171843-22-005368 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearThree | Finance Lease, Liability, to be Paid, Year Three | USD | 0 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001171843-22-005368 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearTwo | Finance Lease, Liability, to be Paid, Year Two | USD | 43,000 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001171843-22-005368 | |
| us-gaap | FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear | Finance Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 66,000 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001171843-22-005368 | |
| us-gaap | FinanceLeaseLiabilityUndiscountedExcessAmount | Finance Lease, Liability, Undiscounted Excess Amount | USD | 2,000 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001171843-22-005368 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001171843-25-001486 |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-15 | 0001171843-24-001380 |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0001171843-23-001729 | |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 10.68M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | FinitelivedIntangibleAssetsAcquired1 | Finite-lived Intangible Assets Acquired | USD | 600,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | USD | 2.80M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001171843-17-001121 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 200,000 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-09 | 0001171843-25-003019 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | USD | 11,000 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-07-30 | 0001171843-25-004826 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 1.00M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 32,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-04 | 0001171843-24-005993 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 182,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-04 | 0001171843-24-005993 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 150,000 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-09 | 0001171843-25-003019 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 11,000 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-07-30 | 0001171843-25-004826 | |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | -400,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | FurnitureAndFixturesGross | Furniture and Fixtures, Gross | USD | 1.13M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001171843-17-001121 | |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | 126,284 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-13 | 0001171843-14-001240 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -6,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | GainLossOnInvestments | Gain (Loss) on Investments | USD | -13,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K/A | 2021-04-26 | 0001171843-21-002766 |
| us-gaap | GainLossOnSaleOfBusiness | Gain (Loss) on Disposition of Business | USD | 300,000 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-09 | 0001171843-25-003019 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 166,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | Goodwill | Goodwill | USD | 7.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | GoodwillAcquiredDuringPeriod | Goodwill, Acquired During Period | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-11 | 0001171843-22-001790 |
| us-gaap | GoodwillAndIntangibleAssetImpairment | Goodwill and Intangible Asset Impairment | USD | 62.19M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-15 | 0001171843-24-001380 |
| us-gaap | GoodwillForeignCurrencyTranslationGainLoss | Goodwill, Foreign Currency Translation Gain (Loss) | USD | -273,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | GoodwillImpairedAccumulatedImpairmentLoss | Goodwill, Impaired, Accumulated Impairment Loss | USD | 0 | 2019-11-30 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 | |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 0 | 2025-01-01 | 2025-11-30 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | GoodwillTranslationAdjustments | Goodwill, Translation Adjustments (Deprecated 2016-01-31) | USD | -857,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-10 | 0001171843-16-008487 |
| us-gaap | GrossProfit | Gross Profit | USD | 59.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | ImpairmentOfIntangibleAssetsExcludingGoodwill | Impairment of Intangible Assets (Excluding Goodwill) | USD | 697,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001171843-18-001450 |
| us-gaap | ImpairmentOfIntangibleAssetsFinitelived | Impairment of Intangible Assets, Finite-lived | USD | 2.46M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001171843-25-001486 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 300,000 | 2012-10-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001171843-15-001395 |
| us-gaap | IncomeLossFromContinuingOperations | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | USD | -2.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -10.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -1.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 940,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | 3.01M | 2012-01-01 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-07 | 0001157523-12-002604 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicShare | Income (Loss) from Continuing Operations, Per Basic Share | USD/shares | -0.15 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncomeLossFromContinuingOperationsPerDilutedShare | Income (Loss) from Continuing Operations, Per Diluted Share | USD/shares | -0.15 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTax | Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity | Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 993,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K/A | 2021-04-26 | 0001171843-21-002766 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 1.08M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 295,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability | Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability | USD | -2.30M | 2017-12-22 | 2017 | FY | 10-K | 2018-02-27 | 0001171843-18-001450 | |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | -13,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -1.95M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount | USD | 1.90M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001171843-20-007600 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 43,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.09M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 1.50M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-04 | 0001171843-24-005993 |
| us-gaap | IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | USD | -124,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | IncomeTaxReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount | USD | 591,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 207,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 416,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -455,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 645,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncreaseDecreaseInAccruedIncomeTaxesPayable | Increase (Decrease) in Income Taxes Payable | USD | 958,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 541,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 1.09M | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-01 | 0001171843-16-012756 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -50,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001171843-17-001121 |
| us-gaap | IncreaseDecreaseInIncomeTaxes | Increase (Decrease) in Income Taxes | USD | 5.91M | 2014-04-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-04 | 0001171843-14-003693 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 14.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -2.08M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001171843-25-001486 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | -708,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001171843-18-001450 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | -25,497 | 2013-01-01 | 2013-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001171843-14-005281 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 1.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | IncreaseDecreaseInPrepaidTaxes | Increase (Decrease) in Prepaid Taxes | USD | 1.20M | 2015-01-01 | 2015-03-31 | 2016 | Q1 | 10-Q | 2016-05-03 | 0001171843-16-009632 |
| us-gaap | IncrementalCommonSharesAttributableToContingentlyIssuableShares | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares | shares | 500,000 | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-06 | 0001157523-13-003914 |
| us-gaap | IncrementalCommonSharesAttributableToConversionOfDebtSecurities | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities | shares | 738,687 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-13 | 0001171843-14-001240 |
| us-gaap | IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends | Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends | shares | 54,124 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001157523-13-001397 |
| us-gaap | IntangibleAssetsCurrent | Intangible Assets, Current | USD | 1.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | IntangibleAssetsGrossExcludingGoodwill | Intangible Assets, Gross (Excluding Goodwill) | USD | 15.74M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 1.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 1.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 126,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-10 | 0001171843-16-008487 |
| us-gaap | InventoryAdjustments | Inventory Adjustments | USD | 3.50M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001171843-19-001243 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 4.41M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001171843-14-005281 | |
| us-gaap | InventoryFinishedGoodsNetOfReserves | Inventory, Finished Goods, Net of Reserves | USD | 8.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 30.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | InventoryNoncurrent | Inventory, Noncurrent | USD | 3.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | InventoryRawMaterials | Inventory, Raw Materials, Gross | USD | 6.84M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001171843-14-005281 | |
| us-gaap | InventoryRawMaterialsNetOfReserves | Inventory, Raw Materials, Net of Reserves | USD | 13.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | InventoryRecallExpense | Inventory Recall Expense | USD | 1.10M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K/A | 2021-04-26 | 0001171843-21-002766 |
| us-gaap | InventoryValuationReserves | Inventory Valuation Reserves | USD | 3.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | InventoryWorkInProcess | Inventory, Work in Process, Gross | USD | 2.33M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001171843-14-005281 | |
| us-gaap | InventoryWorkInProcessNetOfReserves | Inventory, Work in Process, Net of Reserves | USD | 11.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 3.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | InvestmentIncomeAmortizationOfDiscount | Investment Income, Amortization of Discount | USD | 1.07M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-10-28 | 0001171843-19-006886 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 1.80M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001171843-19-001243 |
| us-gaap | LeaseCost | Lease, Cost | USD | 3.83M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001171843-25-001486 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 27.80M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001171843-17-001121 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 18.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 2.85M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 2.77M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 2.77M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 2.77M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 2.77M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 720,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0001171843-22-007281 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 6.49M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 189.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 26.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation | Disposal Group, Including Discontinued Operation, Liabilities | USD | 4.78M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Liabilities, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent | Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | LineOfCreditFacilityAmountOutstanding | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) | USD | 16.00M | 2008-01-31 | 2013 | FY | 10-K | 2014-03-13 | 0001171843-14-001240 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 9.60M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-13 | 0001171843-14-001240 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 1.60M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-13 | 0001171843-14-001240 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 1.60M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001157523-13-001397 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 6.40M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001157523-13-001397 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 6.40M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001157523-13-001397 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 1.60M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001157523-13-001397 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 25.00M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001171843-20-007600 | |
| us-gaap | MachineryAndEquipmentGross | Machinery and Equipment, Gross | USD | 27.46M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001171843-17-001121 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 25.77M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-04-30 | 0001171843-26-002852 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | -11.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 209,000 | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-07-28 | 0001171843-17-004447 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -4.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -8.42M | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-07-28 | 0001171843-17-004447 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | 2.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | 21.73M | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-07-28 | 0001171843-17-004447 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -2.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 | Noncash or Part Noncash Acquisition, Value of Assets Acquired | USD | 50.54M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-03-13 | 0001157523-12-001365 |
| us-gaap | NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 | Noncash or Part Noncash Acquisition, Value of Liabilities Assumed | USD | 16.66M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-03-13 | 0001157523-12-001365 |
| us-gaap | NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1 | Noncash or Part Noncash Divestiture, Amount of Consideration Received | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | pure | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | pure | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | NumberOfReportingUnits | Number of Reporting Units | pure | 2 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -3.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 2.91M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 600,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0001171843-22-007281 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 26.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 24.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.98M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 25.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 1.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 8.70M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 1.88M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 414,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 1.67M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 1.92M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 1.92M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 4.70M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-13 | 0001171843-14-001240 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.037 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 7.50M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-06 | 0001171843-20-001536 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 600,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 3.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | -1,000 | 2015-01-01 | 2015-09-30 | 2016 | Q3 | 10-Q | 2016-11-01 | 0001171843-16-012756 |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) | USD | 756,461 | 2012-01-01 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-07 | 0001157523-12-002604 |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent | USD | -458,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | -1.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -88,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) | USD | -519,405 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-13 | 0001157523-12-001365 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | 548,000 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-01 | 0001171843-16-012756 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | 431 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001171843-14-005281 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 733,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-15 | 0001171843-24-001380 |
| us-gaap | OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities | Other than Temporary Impairment Losses, Investments, Available-for-sale Securities | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001171843-17-001121 |
| us-gaap | PaymentForContingentConsiderationLiabilityFinancingActivities | Payment for Contingent Consideration Liability, Financing Activities | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001171843-25-001486 |
| us-gaap | PaymentsForProceedsFromOtherInvestingActivities | Payments for (Proceeds from) Other Investing Activities | USD | -105,300 | 2010-01-01 | 2010-09-30 | 2011 | Q3 | 10-Q | 2011-11-04 | 0001157523-11-006495 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 9.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 1.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 74,000 | 2009-01-01 | 2009-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001157523-13-001397 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 1.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | PaymentsToAcquireBusinessesNetOfCashAcquired | Payments to Acquire Businesses, Net of Cash Acquired | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-15 | 0001171843-24-001380 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0001171843-23-001729 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 4.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 1.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 3.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | PrepaidTaxes | Prepaid Taxes | USD | 412,301 | 2014-12-31 | 2015 | Q3 | 10-Q | 2015-11-03 | 0001171843-15-005922 | |
| us-gaap | ProceedsFromDivestitureOfBusinessesNetOfCashDivested | Proceeds from Divestiture of Businesses, Net of Cash Divested | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0001171843-23-001729 |
| us-gaap | ProceedsFromOtherEquity | Proceeds from Other Equity | USD | 294,106 | 2014-04-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-04 | 0001171843-14-003693 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-15 | 0001171843-24-001380 |
| us-gaap | ProceedsFromSaleOfIntangibleAssets | Proceeds from Sale of Intangible Assets | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | ProceedsFromSaleOfNotesReceivable | Proceeds from Sale of Notes Receivable | USD | 266,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | ProceedsFromSaleOfOtherAssets1 | Proceeds from Sale of Other Assets | USD | 530,865 | 2013-01-01 | 2013-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001171843-14-005281 |
| us-gaap | ProceedsFromSaleOfOtherAssetsInvestingActivities | Proceeds from Sale of Other Assets, Investing Activities | USD | 188,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-10 | 0001171843-16-008487 |
| us-gaap | ProceedsFromSaleOfProductiveAssets | Proceeds from Sale of Productive Assets | USD | 246,785 | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-06 | 0001157523-13-003914 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 187,735 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-13 | 0001171843-14-001240 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 12,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 198,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | ProductWarrantyAccrual | Standard and Extended Product Warranty Accrual | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | ProductWarrantyExpense | Product Warranty Expense | USD | 0 | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-04 | 0001171843-15-002462 |
| us-gaap | PropertyPlantAndEquipmentDisposals | Property, Plant and Equipment, Disposals | USD | 9.80M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001171843-18-001450 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 96.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 40.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | ProvisionForDoubtfulAccounts | Accounts Receivable, Credit Loss Expense (Reversal) | USD | 312,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0001171843-23-001729 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 21.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 2.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | RestructuringCosts | Restructuring Costs | USD | 2.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | RestructuringCostsAndAssetImpairmentCharges | Restructuring Costs and Asset Impairment Charges | USD | 2.50M | 2012-10-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001171843-15-001395 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 1.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | RestructuringReserveAccrualAdjustment | Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) | USD | 287,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-10 | 0001171843-16-008487 |
| us-gaap | RestructuringReserveCurrent | Restructuring Reserve, Current | USD | 8,384 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001171843-15-001395 | |
| us-gaap | RestructuringReserveSettledWithCash | Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31) | USD | 630,804 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-06 | 0001157523-13-002386 |
| us-gaap | RestructuringReserveTranslationAdjustment | Restructuring Reserve, Foreign Currency Translation Gain (Loss) | USD | -1,589 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001171843-15-001395 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | 58.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 92.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 78.60M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-10-26 | 0001171843-18-007266 |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 121,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0001171843-23-001729 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 1.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | SalesRevenueGoodsNet | Sales Revenue, Goods, Net (Deprecated 2018-01-31) | USD | 107.78M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001171843-18-001450 |
| us-gaap | SalesRevenueGoodsNetPercentage | Sales Revenue, Goods, Net, Percentage (Deprecated 2013-01-31) | pure | 1 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001157523-13-001397 | |
| us-gaap | SalesRevenueNet | Revenue, Net (Deprecated 2018-01-31) | USD | 113.42M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001171843-18-001450 |
| us-gaap | SalesRevenueServicesNet | Sales Revenue, Services, Net (Deprecated 2018-01-31) | USD | 5.64M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001171843-18-001450 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 40.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | SettlementLiabilitiesCurrent | Settlement Liabilities, Current | USD | 3.25M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0001171843-23-003106 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 12.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 134,041 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 23.09 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 569,042 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 14.85 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 953,713 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 20.41 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 317,850 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | USD | 203,485 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001157523-13-001397 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 25.86 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.416 | 2025-01-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-07-29 | 0001171843-26-005012 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.038 | 2025-01-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-07-29 | 0001171843-26-005012 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.007 | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-06 | 0001157523-13-003914 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.006 | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-06 | 0001157523-13-003914 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized | shares | 650,000 | 2013-05-19 | 2013-06-18 | 2013 | Q2 | 10-Q | 2013-08-06 | 0001157523-13-003914 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 900,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-06 | 0001171843-22-003350 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 102,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-04 | 0001171843-24-005993 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 0 | 2025-01-01 | 2025-06-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001171843-25-007032 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value | USD/shares | 30 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001171843-25-001486 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 340,315 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 16,300 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 12.71 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | USD/shares | 31.42 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 1,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 1.77M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 32.07 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 248,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-04 | 0001171843-24-005993 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 1.77M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 31.42 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 290,704 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-13 | 0001171843-14-001240 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 1.35M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 32.6 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 34.51 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate | pure | 0.012 | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-04 | 0001171843-15-002462 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 248,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 137.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 16.82M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-03-13 | 0001157523-12-001365 |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 198,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 833 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 16.82M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-03-13 | 0001157523-12-001365 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 261,000 | 2025-04-01 | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Forfeitures | USD | 0 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0001171843-23-001729 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 0 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 76,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 12,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | StockRepurchasedAndRetiredDuringPeriodShares | Stock Repurchased and Retired During Period, Shares | shares | 133,774 | 2014-04-01 | 2014-06-30 | 2015 | FY | 10-K | 2016-03-10 | 0001171843-16-008487 |
| us-gaap | StockRepurchasedAndRetiredDuringPeriodValue | Stock Repurchased and Retired During Period, Value | USD | 6.35M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-24 | 0001171843-17-001121 |
| us-gaap | StockRepurchasedDuringPeriodShares | Stock Repurchased During Period, Shares | shares | 3.97M | 2025-01-01 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 852,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | StockRepurchaseProgramAuthorizedAmount1 | Stock Repurchase Program, Authorized Amount | USD | 50.00M | 2019-05-02 | 2021 | FY | 10-K | 2022-03-11 | 0001171843-22-001790 | |
| us-gaap | TangibleAssetImpairmentCharges | Tangible Asset Impairment Charges | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | TaxBenefitFromStockOptionsExercised | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) | USD | -394,076 | 2012-01-01 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-07 | 0001157523-12-002604 |
| us-gaap | TaxBenefitFromStockOptionsExercised1 | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) | USD | 64,642 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-06 | 0001157523-13-002386 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 300,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities | USD | 3,089 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001157523-13-001397 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 38,329 | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-03-13 | 0001171843-14-001240 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 38,329 | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001171843-15-001395 |
| us-gaap | UnrecognizedTaxBenefitsPeriodIncreaseDecrease | Unrecognized Tax Benefits, Period Increase (Decrease) | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-10 | 0001171843-16-008487 |
| us-gaap | UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations | USD | 56,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-10 | 0001171843-16-008487 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 3.16M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001171843-26-001275 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-07-29 | 0001171843-26-005012 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 13.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |
| us-gaap | WeightedAverageNumberOfSharesIssuedBasic | Weighted Average Number of Shares Issued, Basic | shares | 14.28M | 2020-10-01 | 2020-12-31 | 2020 | FY | 10-K/A | 2021-04-26 | 0001171843-21-002766 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 13.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001171843-26-007230 |